HALEON PLC (HLN)

London
330.00
+1.95(+0.59%)
  • Volume:
    15,243,355
  • Bid/Ask:
    320.00/347.00
  • Day's Range:
    326.30 - 331.90

HLN Overview

Prev. Close
328.05
Day's Range
326.3-331.9
Revenue
11.22B
Open
326.3
52 wk Range
241.17-357.65
EPS
0.12
Volume
15,243,355
Market Cap
30.47B
Dividend (Yield)
2.40
(0.71%)
Average Vol. (3m)
15,594,372
P/E Ratio
28.51
Beta
-
1-Year Change
-
Shares Outstanding
9,234,573,831
Next Earnings Date
Aug 02, 2023
What is your sentiment on HALEON?
or
Market is currently closed. Voting is open during market hours.

HALEON PLC Company Profile

HALEON PLC Company Profile

Employees
0

Haleon plc is a consumer healthcare company. The Company’s product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Read More

Analyst Price Target

Average361.81 (+9.64% Upside)
High410.00
Low300.00
Price330.00
No. of Analysts16
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralSellSellSellStrong Buy
Technical IndicatorsStrong SellBuyStrong BuyStrong SellStrong Buy
SummarySellNeutralNeutralStrong SellStrong Buy
  • what is the future of this business?
    0
    • As usual well done 🤪
      0
      • And share holders are left with less shares of GSK then what they had before merger - and useless Haleon shares
        1
        • As for GSK i can say that these guys habe lost the ability to compete and sell - they dont know how it should look like
          0
          • As can be seen there is no advantage to share holders - i sold my Haleon shares immediately- the only way is down
            1
            • Gsk consumer was always run separately from the rest of the business units - there will be no advantage to the business with the spin off
              0